CON Approved for Methodist Le Bonheur Healthcare

Bass, Berry & Sims served as co-counsel to Methodist Le Bonheur Healthcare (MLH) in its efforts to obtain a Certificate of Need (CON) to initiate radiation therapy at its hospital campus located in Germantown, Tennessee. Despite opposition from two hospital systems in the Memphis-area, state regulators voted to approve the project by a 2-to-1 margin. MLH will deliver radiation therapy in Germantown using a state-of-the-art MRI-guided linear accelerator, which will be the first of its kind in Tennessee and one of only 10 in the United States. “We’re incredibly excited to receive this approval as we continue our work to create a comprehensive cancer program focused on providing expert cancer care across all of the communities we serve,” said MLH President & CEO Michael Ugwueke. This approval marks an important milestone as MLH works to create the new Methodist Cancer Institute in partnership with University of Tennessee Health Science Center.

Founded 100 years ago, MLH is one of the leading healthcare providers in the Mid-South region with nearly 2.2 million patient encounters in 2018. With seven hospitals, multiple outpatient and diagnostic centers, and a growing network of physician practices, MLH offers a comprehensive continuum of care and is a nationally recognized leader is multiple specialties, including cardiology, neurology and organ transplants.

You Also May Be Interested In:

  • Representation of Bravo Wellness, a national provider of employee wellness solutions and portfolio company of ABS Capital, in its sale to Medical Mutual, a health insurance company based in Ohio

    We represented Bravo Wellness, an ABS Capital portfolio company, in its sale to Medical Mutual, a health insurance company based...
    Client Type: Private Company
  • Representation of MyHealthDirect, a digital care coordination platform, in its sale to Experian Health

    We represented MyHealthDirect, a provider of digital care coordination platform that optimizes scheduling for providers, payers and consumers, in its...
    Client Type: Private Company
  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company